NCT05637489

Brief Summary

This is a randomized controlled trial of the Patient-Initiated Note about Goals (PING).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2022

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

November 21, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 5, 2022

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

October 23, 2025

Status Verified

October 1, 2025

Enrollment Period

3.7 years

First QC Date

November 21, 2022

Last Update Submit

October 22, 2025

Conditions

Chronic Disease

Outcome Measures

Primary Outcomes (1)

  • Number of participants with subsequent goals of care conversation

    Conversation documented in EHR (electronic health record)

    2 months

Study Arms (2)

Treatment

EXPERIMENTAL

Patients receive PING administered by RN

Behavioral: PING

Control

NO INTERVENTION

Usual care

Interventions

PINGBEHAVIORAL

Brief survey of goals and preferences

Treatment

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient referred for Annual Wellness Visit at participating clinic

You may not qualify if:

  • Non-English speaking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke Health

Durham, North Carolina, 27710, United States

Location

MeSH Terms

Conditions

Chronic Disease

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • David J Casarett, MD

    Duke Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Parallel RCT
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 21, 2022

First Posted

December 5, 2022

Study Start

February 1, 2022

Primary Completion

October 1, 2025

Study Completion

October 1, 2025

Last Updated

October 23, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations

US(1)